Cover Image

Effectiveness and Safety of a Fixed-Dose Combination of Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patients with Concomitant Hypertension and Hyperlipidemia: An Observational Study

Kwang Je Lee,1 Jae-Kean Ryu,2 Yun-Hyeong Cho,3 Won Yong Shin,4 Jeong Su Kim,5 Young Won Yoon,6 Ji Yong Jang,7 Won Ho Kim,8 Jong Wook Beom,9 Seok-Min Kang10 On behalf of LG-VROS001 STUDY INVESTIGATOR GROUP1Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea; 2Department of In...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lee KJ (Author), Ryu JK (Author), Cho YH (Author), Shin WY (Author), Kim JS (Author), Yoon YW (Author), Jang JY (Author), Kim WH (Author), Beom JW (Author), Kang SM (Author)
Format:	Book
Published:	Dove Medical Press, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
by: Yoon DY, et al.
Published: (2020)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
by: Oh M, et al.
Published: (2019)

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
by: Jung JA, et al.
Published: (2015)

Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects
by: Ryu H, et al.
Published: (2024)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
by: Oh M, et al.
Published: (2018)

Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers
by: Kim TE, et al.
Published: (2017)

SAFETY AND EFFICACY OF ROSUVASTATIN FOR HYPERLIPIDEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 3 AND ABOVE
by: Jun Yuto, et al.
Published: (2012)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
by: Park JS, et al.
Published: (2016)

Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study
by: Mahmoud M. A. Elsayed, et al.
Published: (2022)

Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
by: Varagic J, et al.
Published: (2014)

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
by: Vilela-Martin JF
Published: (2016)

A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects
by: Kim E, et al.
Published: (2019)

Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants
by: Jin-Woo Park, et al.
Published: (2024)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
by: Kim H, et al.
Published: (2018)

EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK
by: I. M. Sokolov, et al.
Published: (2015)

EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK
by: I. M. Sokolov, et al.
Published: (2015)

The effect of fixed-dose combination of valsartan and amlodipine on nighttime blood pressure in patients with non-dipper hypertension
by: Doğan Erdoğan, et al.
Published: (2016)

THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS
by: O. D. Ostroumova, et al.
Published: (2018)

Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
by: Moon SJ, et al.
Published: (2019)

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects
by: Song H, et al.
Published: (2024)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
by: Nor Hidayah Mustafa, et al.
Published: (2022)

Clinical utility of valsartan in treatment of children and adolescents with high blood pressure
by: Kaushik M, et al.
Published: (2011)

Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan
by: Lee JY, et al.
Published: (2015)

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
by: Kim CH, et al.
Published: (2017)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
by: Oh M, et al.
Published: (2017)

Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment
by: Kateryna Peleshok, et al.
Published: (2021)

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
by: Cheryl L Laffer, et al.
Published: (2011)

The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed‐Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects
by: Chisato Nishida, et al.
Published: (2019)

The Antimycotic Activity of Rosuvastatin
by: Zahraa Qasim
Published: (2022)

Current perspectives on rosuvastatin
by: Hu M, et al.
Published: (2013)

Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects
by: A. L. Khokhlov, et al.
Published: (2022)

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial
by: Cho EJ, et al.
Published: (2018)

Public Perspective on Hyperlipidemia Drugs and Sentiments About Hyperlipidemia on Twitter
by: Murojil Hasan, et al.
Published: (2023)

Public Perspective on Hyperlipidemia Drugs and Sentiments About Hyperlipidemia on Twitter
by: Murojil Hasan, et al.
Published: (2023)

Changes in urinary output due to concomitant administration of sacubitril/valsartan and atrial natriuretic peptide in patients with heart failure: a multicenter retrospective cohort study
by: Tatsuki Yanagawa, et al.
Published: (2024)

Efficacy, Safety and Tolerability of Valsartan and Hydrochlorothiazide Compared to Valsartan and Amlodipine in Stage 2 Hypertension
by: Abdul karim, et al.
Published: (2022)

The Effect of HK-1001 Pharmacopuncture on Hyperlipidemia Induced Rats
by: Hong Kwon-Eui, et al.
Published: (2008)

Hyperlipidemia medication management in patients admitted for a myocardial infarction
by: Shuster JE, et al.
Published: (2011)